Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oxtex was a University of Oxford spinout medical device company developing anisotropic self-inflating tissue expanders based on hydrogel technology. Its products were designed to provide controlled soft-tissue expansion for reconstructive plastic surgery, oral and dental surgery, and related applications such as scar revision, post-tumor reconstruction, and correction of congenital defects. The company also explored veterinary applications for its expansion technology. Oxtex appears to have remained a private venture-backed device developer rather than a commercial-stage therapeutics company. Multiple business databases now classify the company as closed or out of business, with liquidation reported in 2019.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oxtex.